Tamar D Wohlfarth
Affiliation: Medicines Evaluation Board of the Netherlands
Country: The Netherlands
- Response to tricyclic antidepressants: independent of gender?Tamar Wohlfarth
Medicines Evaluation Board of the Netherlands, Den Haag, The Netherlands
Am J Psychiatry 161:370-2. 2004..The authors examined gender differences in response to tricyclic antidepressants...
- Antidepressants use in children and adolescents and the risk of suicideTamar D Wohlfarth
Medicenes Evaluation Board of the Netherlands, The Hague
Eur Neuropsychopharmacol 16:79-83. 2006..Antidepressants use in paediatric patients has been linked with risk of suicidal behaviours. The aim of this paper, therefore, is to examine whether all antidepressants are associated with such risk...
- Psychopharmacology for children: from off label use to registrationTamar Wohlfarth
Medicines Evaluation Board of the Netherlands, The Netherlands
Eur Neuropsychopharmacol 19:603-8. 2009..Specific methodological issues were discussed, such as the role of different informants and the high rate of comorbidity...